Literature DB >> 3957434

Reinfection in erythema migrans disease.

K Weber, G Schierz, B Wilske, U Neubert, H E Krampitz, A G Barbour, W Burgdorfer.   

Abstract

Two patients received oral penicillin for erythema migrans disease (EMD) in 1973 and 1977. Five and seven years later, respectively, they developed EMD for a second time after being bitten by ticks. The first and second erythema migrans lesions appeared in different places. Tests of sera evaluated for antibodies to Borrelia burgdorferi before (in one case), during and after the second episode of EMD remained negative (patient 1) or yielded an at least four-fold rise of IgG antibody titers, but did not become positive (patient 2). These cases provide evidence that reinfection in EMD may occur without a significant elevation of specific antibody titers.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3957434     DOI: 10.1007/bf01644807

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  22 in total

1.  Inoculation syphilis in human volunteers.

Authors:  H J MAGNUSON; E W THOMAS; S OLANSKY; B I KAPLAN; L DE MELLO; J C CUTLER
Journal:  Medicine (Baltimore)       Date:  1956-02       Impact factor: 1.889

2.  Erythema chronicum migrans with multiple lesions.

Authors:  C E Sonck
Journal:  Acta Derm Venereol       Date:  1965       Impact factor: 4.437

3.  Differences between Lyme disease and European arthropod-borne Borrelia infections.

Authors:  G Stanek; G Wewalka; V Groh; R Neumann; W Kristoferitsch
Journal:  Lancet       Date:  1985-02-16       Impact factor: 79.321

4.  [Jarisch-Herxheimer reaction in erythema migrans disease].

Authors:  K Weber
Journal:  Hautarzt       Date:  1984-11       Impact factor: 0.751

5.  Enzyme-linked immunosorbent assay and indirect immunofluorescence assay for Lyme disease.

Authors:  H Russell; J S Sampson; G P Schmid; H W Wilkinson; B Plikaytis
Journal:  J Infect Dis       Date:  1984-03       Impact factor: 5.226

6.  Antibody response in Lyme disease: evaluation of diagnostic tests.

Authors:  J E Craft; R L Grodzicki; A C Steere
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

7.  Serological diagnosis of erythema migrans disease and related disorders.

Authors:  B Wilske; G Schierz; V Preac-Mursic; K Weber; H W Pfister; K Einhäupl
Journal:  Infection       Date:  1984 Sep-Oct       Impact factor: 3.553

8.  Erythema chronicum migrans of Lyme disease.

Authors:  B W Berger
Journal:  Arch Dermatol       Date:  1984-08

9.  Chronic meningitis caused by a penicillin-sensitive microorganism?

Authors:  B Sköldenberg; G Stiernstedt; A Gårde; G Kolmodin; A Carlström; C E Nord
Journal:  Lancet       Date:  1983-07-09       Impact factor: 79.321

10.  The spirochetal etiology of erythema chronicum migrans Afzelius.

Authors:  E Asbrink; B Hederstedt; A Hovmark
Journal:  Acta Derm Venereol       Date:  1984       Impact factor: 4.437

View more
  8 in total

1.  Two-year survey of the incidence of Lyme borreliosis and tick-borne encephalitis in a high-risk population in Sweden.

Authors:  R Gustafson; B Svenungsson; M Forsgren; A Gardulf; M Granström
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-10       Impact factor: 3.267

2.  Characterization of the protective antibody response to Borrelia burgdorferi in experimentally infected LSH hamsters.

Authors:  J L Schmitz; R F Schell; S D Lovrich; S M Callister; J E Coe
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 3.  Childhood Lyme borreliosis in Europe.

Authors:  H I Huppertz
Journal:  Eur J Pediatr       Date:  1990-09       Impact factor: 3.183

4.  Nucleotide sequence of the ospAB operon of a Borrelia burgdorferi strain expressing OspA but not OspB.

Authors:  H Eiffert; A Ohlenbusch; W Fehling; H Lotter; R Thomssen
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

5.  Reinfection in Lyme borreliosis.

Authors:  H Eiffert; F Hanefeld; R Thomssen; H J Christen
Journal:  Infection       Date:  1996 Nov-Dec       Impact factor: 3.553

6.  Borreliacidal activity of sera from hamsters infected with the Lyme disease spirochete.

Authors:  S D Lovrich; S M Callister; J L Schmitz; J D Alder; R F Schell
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

7.  Evaluation of the Importance of VlsE Antigenic Variation for the Enzootic Cycle of Borrelia burgdorferi.

Authors:  Artem S Rogovskyy; Timothy Casselli; Yvonne Tourand; Cami R Jones; Jeb P Owen; Kathleen L Mason; Glen A Scoles; Troy Bankhead
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

8.  Variable VlsE is critical for host reinfection by the Lyme disease spirochete.

Authors:  Artem S Rogovskyy; Troy Bankhead
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.